Bill Hunter

Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA.

Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada.

Rex Bionics Plc engages in the development and manufacture of hands-free robotic exoskeletons designed to enable a wheelchair user to stand and walk. The company was founded by Richard Little and Robert Irving on November 13, 2007 and is headquartered in Marlow, the United Kingdom.

Union MedTech Plc is engaged in employing a buy and build strategy in the medical device arena. It is seeking to acquire and aggregate a number of proprietary medical device technologies in the areas, like orthopaedic and cardiac devices, as well as in novel areas such as bringing together complementary drug and device technologies. The company is focused on aggregating complementary technologies and adding significant value through clinical advancement, operational synergies and experienced management. The company was founded on November 13, 2007 and is headquartered in London, the United Kingdom.

Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.

AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases.

Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada.

Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia.

SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada.

Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand.

BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia.